ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2015 087 872.8, EP file number: 20 21 1096.1 (Designation/title: (R) UND (S) ENANTIOMERE DES N-(5-(3-HYDROXYPYRROLIDIN-1-YL)-2-MORPHOLINOOXAZOLO[4,5-B]PYRIDIN-6-YL)-2-(2-METHYLPYRIDIN-4-YL)OXAZOL-CARBOXAMIDS ALS IRAK4-INHIBITOREN ZUR BEHANDLUNG VON KREBS)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Apr 14, 2021Apr 14, 2021 Filing
2 Q10 Document published May 27, 2021May 27, 2021May 27, 2021 Filing
3 Q10 Document published Mar 6, 2024Mar 6, 2024 Examination
4 Q10 Document published Mar 21, 2024Mar 21, 2024Mar 21, 2024 Examination
5 F10 IP right granted Dec 9, 2024Dec 9, 2024Feb 27, 2025 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Apr 14, 2021Apr 14, 2021 Filing
2 Q10 Document published May 27, 2021May 27, 2021May 27, 2021 Filing
3 Q10 Document published Mar 6, 2024Mar 6, 2024 Examination
4 Q10 Document published Mar 21, 2024Mar 21, 2024Mar 21, 2024 Examination
5 F10 IP right granted Dec 9, 2024Dec 9, 2024Feb 27, 2025 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data